Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 46 | 34 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Myelin Protein Zero (MPZ) gene sequencing test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
MPZ - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Charcot-Marie-Tooth disease Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease NGS panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Comprehensive Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 82 | 71 |
|
Invitae Comprehensive Neuropathies Panel Invitae United States | 201 | 96 |
|
Charcot-Marie-Tooth - Axonal Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 46 | 37 |
|
Charcot-Marie-Tooth - Comprehensive Panel PreventionGenetics, part of Exact Sciences United States | 53 | 44 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.